{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:22:29Z","timestamp":1791933749363,"version":"4.3.4"},"reference-count":156,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["headachejournal.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Headache"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To incorporate recent research findings, expert consensus, and patient perspectives into updated guidance on the use of new acute and preventive treatments for migraine in adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The American Headache Society previously published a Consensus Statement on the use of newly introduced treatments for adults with migraine. This update, which is based on the expanded evidence base and emerging expert consensus concerning postapproval usage, provides practical recommendations in the absence of a formal guideline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This update involved four steps: (1) review of data about the efficacy, safety, and clinical use of migraine treatments introduced since the previous Statement was published; (2) incorporation of these data into a proposed update; (3) review and commentary by the Board of Directors of the American Headache Society and patients and advocates associated with the American Migraine Foundation; (4) consideration of these collective insights and integration into an updated Consensus Statement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Since the last Consensus Statement, no evidence has emerged to alter the established principles of either acute or preventive treatment. Newly introduced acute treatments include two small\u2010molecule calcitonin gene\u2010related peptide (CGRP) receptor antagonists (ubrogepant, rimegepant); a serotonin (5\u2010HT\n                      <jats:sub>1F<\/jats:sub>\n                      ) agonist (lasmiditan); a nonsteroidal anti\u2010inflammatory drug (celecoxib oral solution); and a neuromodulatory device (remote electrical neuromodulation). New preventive treatments include an intravenous anti\u2010CGRP ligand monoclonal antibody (eptinezumab). Several modalities, including neuromodulation (electrical trigeminal nerve stimulation, noninvasive vagus nerve stimulation, single\u2010pulse transcranial magnetic stimulation) and biobehavioral therapy (cognitive behavioral therapy, biofeedback, relaxation therapies, mindfulness\u2010based therapies, acceptance and commitment therapy) may be appropriate for either acute and\/or preventive treatment; a neuromodulation device may be appropriate for acute migraine treatment only (remote electrical neuromodulation).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The integration of new treatments into clinical practice should be informed by the potential for benefit relative to established therapies, as well as by the characteristics and preferences of individual patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/head.14153","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T09:24:07Z","timestamp":1624440247000},"page":"1021-1039","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":717,"title":["The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice"],"prefix":"10.1111","volume":"61","author":[{"given":"Jessica","family":"Ailani","sequence":"first","affiliation":[{"name":"Department of Neurology Medstar Georgetown University Hospital Washington DC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0277-5769","authenticated-orcid":false,"given":"Rebecca C.","family":"Burch","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brigham and Women's Hospital Harvard Medical School Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5426-5333","authenticated-orcid":false,"given":"Matthew S.","family":"Robbins","sequence":"additional","affiliation":[{"name":"Department of Neurology Weill Cornell Medicine New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Board of Directors of the American Headache Society","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e3181b12dd3"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-012-1249-9"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt251"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21211"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102415620251"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000252808.97649.21"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480010072027"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2001.041007646.x"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.02.013"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2011.02046.x"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.08.2212"},{"key":"e_1_2_10_15_1","volume-title":"Global Health Estimates 2015: Disease Burden by Cause, Age, Sex, by Country and by Region, 2000\u20132015","author":"World Health Organization","year":"2016"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30299-5"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2016.10.005"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2009.01369.x"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-1084-y"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.12499"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182535d20"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-017-0787-1"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000199"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.6.754"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.134023"},{"issue":"2","key":"e_1_2_10_26_1","first-page":"S1","article-title":"Canadian Headache Society guideline for migraine prophylaxis","volume":"39","author":"Pringsheim T","year":"2012","journal-title":"Can J Neurol Sci"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02748.x"},{"key":"e_1_2_10_28_1","volume-title":"Headaches in Over 12s: Diagnosis and Management","author":"National Institute for Health and Care Excellence","year":"2021"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-15-2"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.20.2599"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.suppl_1.S35"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001256"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.86a.19009"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010634"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813049"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.16711"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13766"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811090"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31606-X"},{"key":"e_1_2_10_40_1","first-page":"1287","article-title":"Efficacy, safety, and tolerability of rimegepant 75 mg, an oral CGRP receptor antagonist, for the acute treatment of migraine: results from a phase 3, double\u2010blind, randomized, placebo\u2010controlled trial, study 301","volume":"58","author":"Lipton LB","year":"2018","journal-title":"Headache"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006641"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz134"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102418762525"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116725"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005857"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13551"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-1033-9"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13663"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420915167"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1994.1404291.x"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01494-9"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.12164"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.12556"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102418811573"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182825055"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2004.04078.x"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2015.1026325"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01546.x"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.12472"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.12583"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.12905"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-016-0717-7"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-017-0740-3"},{"key":"e_1_2_10_64_1","volume-title":"Guidance: Valproate Use by Women and Girls","author":"Medicines and Healthcare Products Regulatory Agency"},{"key":"e_1_2_10_65_1","volume-title":"FDA Drug Safety Communication: Children Born to Mothers Who Took Valproate Products While Pregnant May Have Impaired Cognitive Development"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420938652"},{"issue":"1","key":"e_1_2_10_67_1","first-page":"1","article-title":"Long\u2010term, open\u2010label safety study of rimegepant 75 mg for the treatment of migraine (Study 201): interim analysis of safety and exploratory efficacy (IHC\u2010PO\u2010127)","volume":"39","author":"Lipton RB","year":"2019","journal-title":"Cephalalgia"},{"issue":"15","key":"e_1_2_10_68_1","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.94.15_supplement.1793","article-title":"Rimegepant 75 mg results in reductions in monthly migraine days: secondary analysis of a multicenter, open label long\u2010term safety study of rimegepant for the acute treatment of migraine (1793)","volume":"94","author":"McGinley JS","year":"2020","journal-title":"Neurology"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420920006"},{"key":"e_1_2_10_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa211"},{"key":"e_1_2_10_71_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00226"},{"key":"e_1_2_10_72_1","volume-title":"Drug Approval Package: Elyxyb"},{"key":"e_1_2_10_73_1","volume-title":"Drug Approval Package: Reyvow"},{"key":"e_1_2_10_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13669"},{"key":"e_1_2_10_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14042"},{"key":"e_1_2_10_76_1","volume-title":"Drug Approval Package: Nurtec ODT"},{"key":"e_1_2_10_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13930"},{"key":"e_1_2_10_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13682"},{"key":"e_1_2_10_79_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2000.0200s2014.x"},{"key":"e_1_2_10_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2006.00437.x"},{"key":"e_1_2_10_81_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098933"},{"key":"e_1_2_10_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.12055"},{"key":"e_1_2_10_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2008.01217.x"},{"key":"e_1_2_10_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-009-0019-4"},{"key":"e_1_2_10_85_1","volume-title":"Amendments to the 2011 American Academy of Neurology Clinical Practice Guideline Process Manual","author":"Gronseth GH"},{"key":"e_1_2_10_86_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102413515348"},{"key":"e_1_2_10_87_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002560"},{"key":"e_1_2_10_88_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705848"},{"key":"e_1_2_10_89_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102418759786"},{"key":"e_1_2_10_90_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008743"},{"key":"e_1_2_10_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30083-2"},{"key":"e_1_2_10_92_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.4853"},{"key":"e_1_2_10_93_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709038"},{"key":"e_1_2_10_94_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006640"},{"key":"e_1_2_10_95_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.3859"},{"key":"e_1_2_10_96_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.1212"},{"key":"e_1_2_10_97_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420905132"},{"key":"e_1_2_10_98_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102419858355"},{"key":"e_1_2_10_99_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009169"},{"issue":"1","key":"e_1_2_10_100_1","first-page":"1","article-title":"CGRP antibodies as adjunctive prophylactic therapy for prolonging the therapeutic effect of onabotulinumtoxinA injections among chronic migraine patients (P09)","volume":"59","author":"Yuan H","year":"2020","journal-title":"Headache"},{"key":"e_1_2_10_101_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13843"},{"key":"e_1_2_10_102_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410364676"},{"key":"e_1_2_10_103_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410364677"},{"key":"e_1_2_10_104_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420912726"},{"key":"e_1_2_10_105_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-018-1193-2"},{"key":"e_1_2_10_106_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010600"},{"key":"e_1_2_10_107_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420941839"},{"key":"e_1_2_10_108_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13456"},{"key":"e_1_2_10_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.05.010"},{"key":"e_1_2_10_110_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102418758283"},{"key":"e_1_2_10_111_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2007.00760.x"},{"key":"e_1_2_10_112_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102419888222"},{"key":"e_1_2_10_113_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-1018-8"},{"key":"e_1_2_10_114_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13508"},{"key":"e_1_2_10_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70272-7"},{"key":"e_1_2_10_116_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102414547138"},{"key":"e_1_2_10_117_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420946725"},{"key":"e_1_2_10_118_1","volume-title":"Adherence to Long\u2010Term Therapies: Evidence for Action","author":"World Health Organization"},{"key":"e_1_2_10_119_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-0998-8"},{"key":"e_1_2_10_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.105900"},{"key":"e_1_2_10_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30234-9"},{"key":"e_1_2_10_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32544-7"},{"key":"e_1_2_10_123_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-018-0623-6"},{"key":"e_1_2_10_124_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-017-2942-5"},{"key":"e_1_2_10_125_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13284"},{"key":"e_1_2_10_126_1","doi-asserted-by":"publisher","DOI":"10.1111\/ner.12623"},{"key":"e_1_2_10_127_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10484-008-9060-3"},{"key":"e_1_2_10_128_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.77.s3.13"},{"key":"e_1_2_10_129_1","doi-asserted-by":"publisher","DOI":"10.1177\/2049463715578291"},{"key":"e_1_2_10_130_1","doi-asserted-by":"publisher","DOI":"10.1080\/08964289.1994.9934617"},{"key":"e_1_2_10_131_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-015-7916-z"},{"key":"e_1_2_10_132_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13657"},{"key":"e_1_2_10_133_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04662-5"},{"key":"e_1_2_10_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2020.06.006"},{"key":"e_1_2_10_135_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-019-03802-w"},{"key":"e_1_2_10_136_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.7090"},{"key":"e_1_2_10_137_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c4871"},{"key":"e_1_2_10_138_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.282533"},{"key":"e_1_2_10_139_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14010"},{"key":"e_1_2_10_140_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13772"},{"key":"e_1_2_10_141_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13429"},{"key":"e_1_2_10_142_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000771"},{"issue":"1597","key":"e_1_2_10_143_1","first-page":"70","article-title":"Rimegepant (Nurtec ODT) for acute treatment of migraine","volume":"62","year":"2020","journal-title":"Med Lett Drugs Ther"},{"key":"e_1_2_10_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30282-9"},{"key":"e_1_2_10_145_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-017-0813-3"},{"key":"e_1_2_10_146_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01786.x"},{"key":"e_1_2_10_147_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079904125004079"},{"key":"e_1_2_10_148_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2006.00289.x"},{"key":"e_1_2_10_149_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2006.00633.x"},{"key":"e_1_2_10_150_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102419828967"},{"key":"e_1_2_10_151_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2007.00950.x"},{"key":"e_1_2_10_152_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-016-0542-3"},{"key":"e_1_2_10_153_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2011.01997.x"},{"key":"e_1_2_10_154_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13162"},{"key":"e_1_2_10_155_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.suppl_1.S20"},{"issue":"3","key":"e_1_2_10_156_1","first-page":"429","article-title":"Quantifying the burden of disease: The technical basis for disability\u2010adjusted life years","volume":"72","author":"Murray CJ","year":"1994","journal-title":"Bull World Health Organ"},{"key":"e_1_2_10_157_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1990.tb00847.x"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.14153","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/head.14153","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.14153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:00:36Z","timestamp":1762077636000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/head.14153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":156,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1111\/head.14153"],"URL":"https:\/\/doi.org\/10.1111\/head.14153","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,23]]},"assertion":[{"value":"2021-03-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}